VYTRUS BIOTECH EO -01 (V5P) — Net Asset Quality Index
VYTRUS BIOTECH EO -01 (V5P) has a Net Asset Quality Index of 70.3% as of December 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of €14.66 Million minus total liabilities of €4.35 Million yields net assets of €10.31 Million. A higher index indicates a stronger, lower-leverage balance sheet. Check V5P asset liquidity ratio to evaluate the company's liquid asset resilience ratio.
Quality Index
Net Assets
Total Assets
Total Liabilities
VYTRUS BIOTECH EO -01 Net Asset Quality Index Over Time (2021–2025)
This chart shows how VYTRUS BIOTECH EO -01's Net Asset Quality Index has evolved across 5 annual periods from 2021 to 2025. As of December 2025, the index stands at 70.3%, representing net assets of €10.31 Million against total assets of €14.66 Million EUR. See V5P current assets to equity ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Net Asset Quality Index for VYTRUS BIOTECH EO -01 (2021–2025)
The table below presents the year-by-year Net Asset Quality Index for VYTRUS BIOTECH EO -01 from 2021 to 2025, covering 5 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see how much is VYTRUS BIOTECH EO -01 worth.
| Year | Quality Index | Net Assets (EUR) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 70.3% | €10.31 Million | €14.66 Million | €4.35 Million | ▲ +4.8 pp |
| 2024 | 65.5% | €7.29 Million | €11.13 Million | €3.84 Million | ▲ +8.7 pp |
| 2023 | 56.8% | €5.29 Million | €9.31 Million | €4.02 Million | ▼ -2.6 pp |
| 2022 | 59.4% | €4.75 Million | €8.00 Million | €3.25 Million | ▲ +0.2 pp |
| 2021 | 59.2% | €4.25 Million | €7.18 Million | €2.93 Million | — |